Characterisation of two rat mammary tumour models for breast cancer research by gene expression profiling

Experimental and Toxicologic Pathology

Volumn 58, Issue 2-3, 2006, Pages 133-143

  Marxfeld, Heike ^a,b   Staedtler, Frank ^a   Harleman, Johannes H ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Breast cancer models; DMBA; Gene expression profiling; MTLn3; Rat

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; TUMOR MARKER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HORMONE SENSITIVITY; IMMUNOHISTOCHEMISTRY; METHODOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; TUMOR MODEL;

RODENTIA;

EID: 33750351922     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.05.003     Document Type: Article

References (50)

1. Bange J., Zwick E., and Ullrich A. Molecular targets for breast cancer therapy and prevention. Nat Med 7 (2001) 548-552
2. Brisken C., Heineman A., Chavarria T., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signalling. Genes Dev 14 (2000) 650-654
3. Cardoso F., Durbecq V., Larsimont D., et al. Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancer. Int J Oncol 24 (2004) 201-209
4. Chiu C.M., Tsay Y.G., Chang C.J., et al. Nopp140 is a mediator of the protein kinase A signaling pathway that activates the acute phase response alpha1-acid glycoprotein gene. J Biol Chem 277 (2002) 39102-39111 [Epub 2002 August7]
5. Clarke R., Liu M.C., Bouker K.B., et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22 (2003) 7316-7339
6. Clevenger C.V., Furth P.A., Hankinson S.E., et al. The role of prolactin in mammary carcinoma. Endocr Rev 24 (2003) 1-27
7. D'Cruz C.M., Moody S.E., Master S.R., et al. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16 (2002) 2034-2051
8. Das R., Mahabeleshwar G.H., and Kundu G.C. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. J Biol Chem 279 (2004) 11051-11064 [Epub 2004 January 2]
9. Davidovich I.A., Levenson A.S., and Levenson Chernokhvostov V.V. Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance. Cancer Lett 211 (2004) 189-197
10. Duan Z., Lamendola D.E., Yusuf R.Z., et al. Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res 22 (2002) 1933-1941
11. Fletcher G.C., Patel S., Tyson K., et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 88 (2003) 579-585
12. Fu J.Y., Lyga A., Shi H., et al. Cloning, expression, purification, and characterization of rat MMP-12. Prot Exp Purif 21 (2001) 268-274
13. Garbett E.A., Reed M.W., Stephenson T.J., et al. Proteolysis in human breast cancer. Mol Pathol 53 (2000) 99-106
14. Gillett C., Smith P., Gregory W., et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69 (1996) 92-99
15. Godwin A.K., Meister A., O'Dwyer P.J., et al. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89 (1992) 3070-3074
16. Higuchi Y., Kita K., Nakanishi H., et al. Search for genes involved in UV-resistance in human cells by mRNA differential display: increased transcriptional expression of nucleophosmin and T-plastin genes in association with the resistance. Biochem Biophys Res Commun 248 (1998) 597-602
17. Hisano T., Ono M., Nakayama M., et al. Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display. FEBS Lett 397 (1996) 101-107
18. Holden D.P., Cartwright J.E., Nussey S.S., et al. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108 (2003) 1575-1580 [Epub 2003 September 8]
19. Huggins C., Grand L.C., and Brillantes F.P. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (London) 189 (1961) 204-207
20. Ismail P.M., Amato P., Soyal S.M., et al. Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68 (2003) 779-787
21. Iso T., Hamamori Y., and Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 23 (2003) 543-553 [Epub 2003 February 13]
22. Jin Y., Yu J., and Yu Y.G. Identification of hNopp140 as a binding partner for doxorubicin with a phage display cloning method. Chem Biol 9 (2002) 157-162
23. Johnson M.L., Levy J., and Rosen J.M. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res 43 (1983) 2199-2209
24. Kristiansen G., Pilarsky C., Wissmann C., et al. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54 (2003) 34-43
25. Li Z., Xia L., Lee L.M., et al. Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat Res 155 (2001) 543-553
26. Lin M.T., Chang C.C., Chen S.T., et al. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279 (2004) 24015-24023 [Epub 2004 March 24]
27. Lin S.Y., Xia W., Wang J.C., et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97 (2000) 4262-4266
28. Maiguel D.A., Jones L., Chakravarty D., et al. Nucleophosmin sets a threshold for p53 response to UV radiation. Mol Cell Biol 24 (2004) 3703-3711
29. Menashi S., Serova M., Ma L., et al. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 63 (2003) 7575-7580
30. Mennerich D., Vogel A., Klaman I., et al. Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer 40 (2004) 1373-1382
31. Nakopoulou L., Giannopoulou I., Gakiopoulou H., et al. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 30 (1999) 436-442
32. Nava V.E., Hobson J.P., Murthy S., et al. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 281 (2002) 115-127
33. Neri A., and Nicolson G.L. Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro. Int J Cancer 28 (1981) 731-738
34. Nielsen B.S., Rank F., Lopez J.M., et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 61 (2001) 7091-7100
35. Notarbartolo M., Cervello M., Poma P., et al. Expression of the IAPs in multidrug resistant tumor cells. Oncol Rep 11 (2004) 133-136
36. OMIM (online inheritance in man): http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM&itool=toolbar
37. Paret C., Bourouba M., Beer A., et al. Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration. Int J Cancer 115 (2005) 724-733
38. Parkin D.M., Bray F., Ferlay J., et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
39. Pelosio P., Barbareschi M., Bonoldi E., et al. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann Oncol 7 (1996) 695-703
40. Relf M., Lejeune S., Scott P.A., et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57 (1997) 963-969
41. Schairer C. Progesterone receptors-animal models and cell signalling in breast cancer: implications for breast cancer of inclusion of progestins in hormone replacement therapies. Breast Cancer Res 4 (2002) 244-248 [Epub 2002 October 7]
42. Sommers C.L., Heckford S.E., Skerker J.M., et al. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52 (1992) 5190-5197
43. Sun X., Zhao J., Jin S., et al. A novel protein localized to the fibrillar compartment of the nucleolus and to the brush border of a secretory cell. Eur J Cell Biol 81 (2002) 125-137
44. Swart G.W. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur J Cell Biol 81 (2002) 313-321
45. Uria J.A., Stahle-Backdahl M., Seiki M., et al. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 57 (1997) 4882-4888
46. Usary J., Llaca V., Karaca G., et al. Mutation of GATA3 in human breast tumors. Oncogene 23 (2004) 7669-7678
47. Wang L., Zhang G.M., and Feng Z.H. Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line. Acta Pharmacol Sin 24 (2003) 1235-1240
48. Wang-Rodriguez J., Urquidi V., Rivard A., et al. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status. Breast Cancer Res 5 (2003) R136-R143 [Epub 2003 July 9]
49. Xie W.F., Zhang X., and Sandell L.J. The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol 19 (2000) 501-509
50. Yahata T., Takedatsu H., and Dunwoodie S.L. Cloning of mouse Cited4, a member of the CITED family p300/CBP-binding transcriptional coactivators: induced expression in mammary epithelial cells. Genomics 80 (2002) 601-613